Santen has a history of over 120 years developing new eye care products to protect and preserve vision. We are dedicated to advance treatments by delivering a whole portfolio of innovative drugs, medical devices and services to patients and medical professionals not only in Europe, but worldwide.
As a specialised pharmaceutical company in ophthalmology, Santen offers an extensive and expanding range of pharmaceuticals and medical devices, covering therapeutic areas such as dry eye, glaucoma, cataract, infection, allergy and age related macular degeneration (AMD).
Everything we do is driven by our desire to understand and address the unmet needs of people with eye health or vision issues. Our strategy for product development is driven by three areas of focus:
- Target and address unmet medical needs
- Improve the probability of technical success
- Reduce time to launch and provide treatments faster.
A main focus lies on the development and marketing of unpreserved drugs. We also invest heavily in the research and development of innovative technologies going hand in hand with our existing and future product portfolio.